MAPS Publishes Open Science Approach to Synthesizing MDMA
How do we make psychedelics available for research and therapy? We spoke to Berra Yazar-Klosinski to learn about how MAPS PBC is making cGMP MDMA at scale.
Research
Research Briefing: Ketamine effective for alcoholism, not PTSD?
In the Research Briefing of January 24th: 1) Ketamine effective in abstaining from alcohol for up to 6 months later 2) Real-world data provides further evidence ketamine therapy is effective for depression 3) But a large study finds ketamine not to be effective for PTSD in service members
Top 10 Articles on Psychedelics and Integration
Integration of psychedelic experiences can be key | How the integration after psychedelics can be vital for positive therapeutic outcomes
Research Briefing: Wins for MDMA and psilocybin
In the Research Briefing of January 10th: 1) Psilocybin can be administered safely for up to six people simultaneously 2) An Open Science approach toward MDMA synthesis 3) Nitrous Oxide could be the next antidepressant
Psychedelics Research Links January 2022
This is all the other psychedelic research that came out in January 2022.
Psychedelics Research Recap December 2021
December was another busy month in the world of psychedelic research as 2021 came to a close. The benefits of microdosing remain in dispute, the use of virtuality reality in tandem with psychedelics is further discussed, while we simultaneously gained further insight as to how different psychedelics work in the brain for different disorders, through both experiments and reviews.
Research Briefing: No Blue Mondays after clinical MDMA use?
In the Research Briefing of December 20th: 1) New double-blind study doesn’t find benefits of microdosing 2) The negative post-acute effects of MDMA appear to be absent in the clinical setting
Psychedelics and VR – Interview with David Glowacki
To better understand the science of psychedelics, and how we can make the bridge to implementing them in practice, Blossom is conducting a series of interviews with psychedelic scientists. Our editor-at-large, George Fejer, speaks to David Glowacki, one of the world’s leaders in the use of virtual reality applied to scientific simulation and visualization.
Taking Microdosing with a Pinch of Salt
Microdosing is becoming more popular every day. From Hollywood to small towns all across the word. Is there scientific merit to it, or all placebo? And does a new paper prove the benefits of microdosing?
Psychedelics Research Recap November 2021
November proved to be another productive month for psychedelic research. A variety of surveys looked at how psychedelics alter beliefs, reduce opioid use, and the effects of microdosing. A finished Phase I trial clear 5-MeO-DMT for the next step, cannabis intensifies a psychedelic experience, and psychedelics may help with Alzheimer’s.